Bicycle Therapeutics plc（BCYC）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · BCYC · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$72.59M	$35.27M	$26.98M	$14.46M	$11.70M
Cost of Revenue	$0.00M	$172.97M	$156.50M	$0.00M	$0.00M
Gross Profit	$72.59M	($137.69M)	($129.52M)	$14.46M	$11.70M
Gross Margin %(computed)	100.00%	-390.34%	-480.13%	100.00%	100.00%
Operating Expenses
R&D Expenses	$240.28M	$172.97M	$156.50M	$81.61M	$44.88M
G&A Expenses	$80.02M	$71.46M	$59.83M	$49.51M	$32.44M
Total Operating Expenses	$320.30M	$72.18M	$60.43M	$131.12M	$77.31M
Operating Income	($247.72M)	($209.87M)	($189.95M)	($116.65M)	($65.62M)
Operating Margin %(computed)	-341.28%	-594.96%	-704.13%	-806.56%	-560.98%
Interest Income	$28.46M	$34.28M	$14.00M	$5.76M	$0.12M
Interest Expense	$0.21M	$1.73M	$3.26M	$3.34M	$2.98M
Income Before Tax	($218.81M)	($173.80M)	($179.21M)	($114.24M)	($68.48M)
Income Tax Expense	$0.15M	($4.76M)	$1.46M	($1.52M)	($1.66M)
Net Income	($218.96M)	($169.03M)	($180.66M)	($112.72M)	($66.82M)
Net Margin %(computed)	-301.66%	-479.18%	-669.72%	-779.35%	-571.25%
Per Share & EBITDA
EPS (Basic)	$-3.16	$-2.91	$-5.08	$-3.80	$-2.67
Wtd Avg Shares	69.28M	58.21M	35.59M	29.66M	25.06M
EBITDA	($212.18M)	($164.89M)	($183.40M)	($107.21M)	($64.09M)
EBITDA Margin %(computed)	-292.32%	-467.45%	-679.86%	-741.26%	-547.91%